Humana HUM.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

70.90

+0.42%

Close of 27 Oct 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 10.01bn

FY2016FY2025

Net income

SEK 237.0m

FY2016FY2025

Free cash flow

SEK 666.0m

FY2016FY2025

Shareholders' equity

SEK 3.12bn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	SEK 10.01bn	SEK 10.29bn	SEK 9.65bn	SEK 9.20bn	SEK 8.19bn	SEK 7.77bn	SEK 7.45bn	SEK 6.71bn	SEK 6.54bn	SEK 6.36bn
Operating income	SEK 456.0m	SEK 467.0m	SEK 453.0m	SEK 439.0m	SEK 493.0m	SEK 471.0m	SEK 369.0m	SEK 391.0m	SEK 316.0m	SEK 329.0m
Net income	SEK 237.0m	SEK 144.0m	SEK 176.0m	SEK 210.0m	SEK 276.0m	SEK 262.0m	SEK 188.0m	SEK 245.0m	SEK 194.0m	SEK 148.0m
Diluted earnings per share	4.85	2.78	3.68	4.39	5.70	5.30	3.54	4.61	3.65	2.79

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	SEK 9.39bn	SEK 10.63bn	SEK 10.03bn	SEK 9.81bn	SEK 9.00bn	SEK 8.04bn	SEK 8.23bn	SEK 5.22bn	SEK 5.06bn	SEK 4.96bn
Cash and short-term investments	SEK 366.0m	SEK 583.0m	SEK 675.0m	SEK 690.0m	SEK 695.0m	SEK 759.0m	SEK 836.0m	SEK 514.0m	SEK 584.0m	SEK 465.0m
Total liabilities	SEK 6.14bn	SEK 7.33bn	SEK 7.10bn	SEK 7.07bn	SEK 6.45bn	SEK 5.69bn	SEK 5.92bn	SEK 3.07bn	SEK 3.17bn	SEK 3.23bn
Debt	SEK 4.40bn	SEK 5.15bn	SEK 5.41bn	SEK 5.40bn	SEK 4.92bn	SEK 4.27bn	SEK 4.55bn	SEK 1.89bn	SEK 2.02bn	SEK 2.08bn
Shareholders' equity	SEK 3.12bn	SEK 3.16bn	SEK 2.89bn	SEK 2.74bn	SEK 2.55bn	SEK 2.35bn	SEK 2.28bn	SEK 2.13bn	SEK 1.89bn	SEK 1.73bn
Shares outstanding	49m	52m	48m	48m	48m	49m	53m	53m	53m	53m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	SEK 770.0m	SEK 869.0m	SEK 621.0m	SEK 633.0m	SEK 689.0m	SEK 661.0m	SEK 631.0m	SEK 332.0m	SEK 241.0m	−SEK 161.0m
Capital spending	−SEK 104.0m	−SEK 299.0m	−SEK 170.0m	−SEK 191.0m	−SEK 107.0m	−SEK 133.0m	−SEK 228.0m	−SEK 174.0m	−SEK 151.0m	−SEK 143.0m
Free cash flow	SEK 666.0m	SEK 570.0m	SEK 451.0m	SEK 442.0m	SEK 582.0m	SEK 528.0m	SEK 403.0m	SEK 158.0m	SEK 90.0m	−SEK 304.0m
Dividends paid	−SEK 50.0m	—	—	—	—	—	−SEK 37.0m	−SEK 32.0m	−SEK 27.0m	−SEK 27.0m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	SEK 2.58bn	SEK 2.48bn	SEK 2.48bn	SEK 2.49bn	SEK 2.51bn	SEK 2.53bn	SEK 2.69bn	SEK 2.67bn
Operating income	SEK 43.0m	SEK 99.0m	SEK 82.0m	SEK 205.0m	SEK 75.0m	SEK 203.0m	SEK 108.0m	SEK 195.0m
Net income	−SEK 9.0m	SEK 38.0m	SEK 26.0m	SEK 119.0m	SEK 16.0m	SEK 74.0m	SEK 28.0m	SEK 94.0m
Diluted earnings per share	-0.19	0.80	0.53	2.44	0.33	1.51	0.54	1.81
Cash from operations	SEK 261.0m	SEK 67.0m	SEK 313.0m	SEK 96.0m	SEK 245.0m	SEK 116.0m	SEK 330.0m	SEK 260.0m
Capital spending	−SEK 18.0m	−SEK 13.0m	−SEK 26.0m	−SEK 1.0m	−SEK 23.0m	−SEK 56.0m	−SEK 72.0m	−SEK 87.0m
Free cash flow	SEK 243.0m	SEK 54.0m	SEK 287.0m	SEK 95.0m	SEK 222.0m	SEK 60.0m	SEK 258.0m	SEK 173.0m
Total assets	SEK 9.41bn	SEK 9.46bn	SEK 9.39bn	SEK 9.50bn	SEK 10.01bn	SEK 10.20bn	SEK 10.63bn	SEK 10.52bn
Cash and short-term investments	SEK 339.0m	SEK 254.0m	SEK 366.0m	SEK 298.0m	SEK 645.0m	SEK 658.0m	SEK 583.0m	SEK 449.0m
Debt	SEK 2.12bn	SEK 2.12bn	SEK 4.38bn	SEK 4.51bn	SEK 4.87bn	SEK 5.53bn	SEK 5.15bn	SEK 5.31bn
Shareholders' equity	SEK 3.09bn	SEK 3.16bn	SEK 3.12bn	SEK 3.16bn	SEK 3.09bn	SEK 3.15bn	SEK 3.16bn	SEK 3.12bn

Financial ratios

Data as of 29 Oct 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Operating margin	5.2%	4.5%	3.8%	4.8%	6.0%	6.1%
Net margin	2.4%	1.4%	1.8%	2.3%	3.4%	3.4%
Return on equity	7.6%	4.6%	6.1%	7.7%	10.8%	11.1%
Return on assets	2.5%	1.4%	1.8%	2.1%	3.1%	3.3%
Free cash flow yield	25.2%	31.8%	23.3%	24.3%	23.2%	22.7%
Revenue growth	-2.8%	6.7%	4.8%	12.4%	5.4%	4.4%
Earnings growth	64.6%	-18.2%	-16.2%	-23.9%	5.3%	39.4%
Current ratio	0.67x	0.87x	0.81x	0.95x	1.05x	0.81x
Debt to equity	0.67x	0.78x	0.87x	0.97x	0.93x	0.98x
Equity ratio	33.2%	29.8%	28.8%	27.9%	28.4%	29.3%
Interest coverage	2.26x	1.72x	1.49x	2.61x	3.57x	3.35x
Buybacks as a share of market value	5.7%	-8.4%	0.0%	1.1%	2.1%	7.0%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	2.8%	5.2%	6.0%
Operating income	1.3%	-0.6%	6.6%
Net income	4.1%	-2.0%	17.8%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Operating margin	4.5%	4.6%	5.0%	5.0%
Net margin	1.9%	2.0%	2.4%	2.4%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	10.3	12.8	7.7	4.4	6.4	5.6	8.6	6.5	7.5	12.9
Price to sales	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.3

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 8 May 2026.

	FY2026	FY2025	FY2019	FY2018	FY2017
Paid in the year	1.35	1.00	0.70	0.60	0.50

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Humana HUM.ST · SEK

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology